Cellenkos raises $15M Series A for platform targeting treatments for autoimmune, inflammatory disases
November 04, 2021 at 17:52 PM EDT
Cellenkos was founded by Dr. Simrit Parmar, an associate professor in the lymphoma and myeloma department at M.D. Anderson Cancer Center.
